Clinical Research Studies

Improving the health of our patients through groundbreaking clinical research.

Current Dermatology Clinical Trials

Study: Injectable Treatment to Treat Cutaneous Squamous Cell Carcinoma

Purpose: The purpose of this trial is to evaluate the safety, tolerability, and efficacy of various doses of STP705 administered as intralesional injection in subjects with cutaneous squamous cell carcinoma in situskin cancer(isSCC).

Qualifications:

• Male and Females, 18 years or older
• Current diagnosis of SCC

Duration: Up to 14 weeks
Location: Hackensack, NJ
Compensation: Up to $785

Interested in participating in our clinical research study? Please click here.

---

Study: Injectable Treatment to Treat Keloids

Purpose: To assess the safety, tolerability, and efficacy of various doses of STP705 (10μg, 20μg, 30μg and 40μg) intradermal injection and placebo, when injected into the keloid excision site, to prevent the recurrence of keloids following their excision. The study treatments are administered once per week. There will be four (4) follow-up visits at one (1), three (3), six (6) and nine (9) months after your keloid surgery.

Qualifications:

• Male and Females, 18 – 60 years old
• Have at least one keloid scar present for at least one year on the upper body, arms, or legs

Duration: 54 weeks
Location: Hackensack, NJ
Compensation: Up to $1,100 if all study visits are completed

Interested in participating in our clinical research study? Please click here.

---

Study: Atopic Dermatitis

Purpose: A clinical research study to test the effectiveness of an investigational medication to reduce symptoms. This study will also include 2 vaccines commonly used in adults with moderate-to-severe AD. The main purpose of this study is to learn whether an investigational drug could impact how effective certain vaccines may be and how effective and safe the study drug is in patients with moderate-to-severe AD.

Qualifications:

• Male and Females, ages 18 to 55 years of age
• Have moderate to severe atopic dermatitis for at least 1 year
• Failure to improve with topical prescriptions

Duration: 26 weeks/visiting doctor’s office 10 to 12 times
Locations: Hackensack, NJ
Compensation: If all visits are kept, up to $375 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.

---

Study: Evaluation of the Mind.Px Patch on Response to Biologic Treatment for Patients with Plaque Psoriasis

Purpose: The purpose of this study is to evaluate the impact of Mind.Px on response to biologic treatment for patients suffering from plaque psoriasis, as judged by the mean change in the Psoriasis Area Severity index (PASI) score from baseline to end of Week 16 of the study.

Qualifications:

• Male and Females, 18 years or older
• Current diagnosis of Plaque Psoriasis

Duration: Up to 20 weeks
Locations: Hackensack, NJ
Compensation: Up to $630 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.

---

Study: Safety and Efficacy of Sofwave Treatment for Acne Scars Appearance Improvement

Purpose: To evaluate the clinical efficacy of SofWave treatment to improve acne scars appearance. Eligible patients will receive 3 treatments (4-6 weeks apart) on the facial acne scars using Sofwave System. All patients will return to the clinic for one follow up visit at 3 months post last treatment.

Qualifications:

• Female and male subjects, ages 22 to 80 years
• Mild to moderate facial acne scars

Duration: Approx. 6 months
Locations: Hackensack, NJ
Compensation: Up to $120 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.

---